The Glomerular Revolution: Advances in Rare Kidney Disease Management and Insights from Upcoming Webinar Join the upcoming webinar to discover how biomarkers and innovative strategies are reshaping treatments for rare kidney diseases. Gain valuable insights now!

The Glomerular Revolution: Advances in Rare Kidney Disease Management and Insights from Upcoming Webinar #Canada #Toronto #kidney_disease #Biomarkers #Xtalks

37th Annual NKF Authors Luncheon: Celebrating Storytelling for Kidney Health Join us on March 29, 2026, for the 37th Annual NKF Authors Luncheon in San Francisco, featuring acclaimed authors dedicated to kidney health.

37th Annual NKF Authors Luncheon: Celebrating Storytelling for Kidney Health #USA #San_Francisco #kidney_disease #National_Kidney_Foundation #Authors_Luncheon

Understanding Kidney Disease: Key Insights Everyone Should Know for World Kidney Day March is National Kidney Month. Discover vital facts about kidney disease from the National Kidney Foundation to promote awareness and early detection.

Understanding Kidney Disease: Key Insights Everyone Should Know for World Kidney Day #United_States #New_York #kidney_disease #National_Kidney_Foundation #World_Kidney_Day

Cystatin C Assay Market Anticipated to Surpass $750 Million by 2033 Driven by Rising Kidney Disease Awareness The global Cystatin C Assay Market is set to experience remarkable growth, projected to reach $750.7 million by 2033, fueled by increasing chronic kidney disease prevalence and diagnostic adoption.

Cystatin C Assay Market Anticipated to Surpass $750 Million by 2033 Driven by Rising Kidney Disease Awareness #None #diagnostics #kidney_disease #cystatin_C

Variant Bio Partners with Boehringer Ingelheim to Tackle Kidney Disease Through AI Innovation Variant Bio has established a significant partnership with Boehringer Ingelheim to facilitate the discovery of new targets for treating kidney disease, utilizing cutting-edge AI technology.

Variant Bio Partners with Boehringer Ingelheim to Tackle Kidney Disease Through AI Innovation #USA #Seattle #Boehringer_Ingelheim #kidney_disease #Variant_Bio

Boehringer Ingelheim and Eli Lilly Unite to Promote Kidney Health Awareness through It Takes 2™ Initiative Discover how the It Takes 2™ initiative by Boehringer Ingelheim and Eli Lilly emphasizes the need for complete kidney disease testing and early diagnosis.

Boehringer Ingelheim and Eli Lilly Unite to Promote Kidney Health Awareness through It Takes 2™ Initiative #United_States #Boehringer_Ingelheim #kidney_disease #Ridgefield #It_Takes_2

Celebrating 75 Years of Kidney Health Progress with the National Kidney Foundation The National Kidney Foundation marks its 75th anniversary, celebrating decades of advancements in kidney health and looking ahead to new initiatives to improve care across the nation.

Celebrating 75 Years of Kidney Health Progress with the National Kidney Foundation #United_States #New_York #kidney_disease #National_Kidney_Foundation #CKD

New Documentary 'I Want to Live' Highlights the Impact of Nephrology Nursing Explore the powerful new documentary 'I Want to Live,' showcasing nephrology nurses' vital role in kidney disease care. Premiered at ANNA's symposium.

New Documentary 'I Want to Live' Highlights the Impact of Nephrology Nursing #United_States #Portland #kidney_disease #Anna #Nephrology_Nurses

Alonzo Mourning: Advocating for Kidney Health Awareness and Innovation Alonzo Mourning shares his kidney disease journey, advocating for awareness, early detection, and innovative solutions to support kidney health.

Alonzo Mourning: Advocating for Kidney Health Awareness and Innovation #USA #New_York #kidney_disease #NBA #Alonzo_Mourning

Ready for an exciting day at #ESPN2025. Today Dr Van de Kar will share the first of our two oral presentations on adolescent #C3G and primary #ICMPGN—part of our commitment to advancing understanding of rare #kidney_disease. #Rare_Sobi #Sobi_nephrology
🗓️Thursday 16 October
🕙17.22 EEST
📍TriantiHall

Unraveling the Mutation Mechanism of Thioredoxin in Neurological Diseases A groundbreaking collaborative study reveals the mutation mechanism of thioredoxin that leads to neurodegenerative and chronic kidney diseases, proposing new treatment pathways.

Unraveling the Mutation Mechanism of Thioredoxin in Neurological Diseases #Japan #kidney_disease #Okayama #Thioredoxin #Neurological_Disease

Somatus Achieves Significant Reductions in Mortality Rates Through Comprehensive Care Strategies Somatus' innovative, integrated care model results in a notable 13% decrease in mortality rates among patients at risk for kidney and heart diseases.

Somatus Achieves Significant Reductions in Mortality Rates Through Comprehensive Care Strategies #United_States #healthcare #McLean #kidney_disease #Somatus

Renalytix and Tempus Collaborate to Enhance Kidney Risk Assessment for Diabetic Patients Renalytix has partnered with Tempus AI to expand access to kidneyintelX.dkd testing in the US, aiding diabetic kidney disease risk assessment and management.

Renalytix and Tempus Collaborate to Enhance Kidney Risk Assessment for Diabetic Patients #United_States #New_York #kidney_disease #Tempus_AI #Renalytix

Exploring the Burdens of Dietary Management for Kidney Disease Patients A recent survey reveals that 70% of kidney disease patients find dietary management burdensome, highlighting the need for emotional support.

Exploring the Burdens of Dietary Management for Kidney Disease Patients #Japan #kidney_disease #Sumida #Wellness_Dining #Nutritional_Support

Viatris Launches First Generic Iron Sucrose Injection in the U.S.: A Game Changer for Anemia Management Viatris has received FDA approval for the first generic Iron Sucrose Injection, enhancing treatment options for patients with chronic kidney disease and iron deficiency anemia.

Viatris Launches First Generic Iron Sucrose Injection in the U.S.: A Game Changer for Anemia Management #United_States #Pittsburgh #kidney_disease #Viatris #Iron_Sucrose

MVP Health Care and Renalytix Unite for Kidney Disease Testing to Transform Patient Care MVP Health Care and Renalytix are collaborating to enhance kidney disease testing services, improving health outcomes for those with chronic conditions.

MVP Health Care and Renalytix Unite for Kidney Disease Testing to Transform Patient Care #USA #New_York #kidney_disease #MVP_Health_Care #Renalytix

New Global Study Reveals Nearly Half of Lupus Patients Experience Kidney Complications A recent survey by the World Lupus Federation indicates that 47% of lupus patients report kidney issues, highlighting a serious knowledge gap about lupus nephritis.

New Global Study Reveals Nearly Half of Lupus Patients Experience Kidney Complications #USA #Washington #kidney_disease #Lupus_Nephritis #Lupus

Global Lupus Federation Survey Reveals Alarming Statistics on Kidney Damage Among Lupus Patients A recent survey by the Global Lupus Federation shows that nearly half of lupus patients experience kidney damage, emphasizing the need for awareness and education.

Global Lupus Federation Survey Reveals Alarming Statistics on Kidney Damage Among Lupus Patients #USA #Washington #kidney_disease #Lupus_Federation #Lupus_Awareness

Sankar Dass Navaneethan Honored with Garabed Eknoyan Award by NKF Dr. Sankar Dass Navaneethan has been recognized by the National Kidney Foundation with the prestigious Garabed Eknoyan Award, showcasing his contributions to nephrology.

Sankar Dass Navaneethan Honored with Garabed Eknoyan Award by NKF #United_States #Houston #kidney_disease #National_Kidney_Foundation #Sankar_Navaneethan

Akebia Therapeutics Awards Stock Options to New Employee Under Nasdaq Rule Akebia Therapeutics has granted stock options to a newly-hired employee in compliance with Nasdaq Listing Rule 5635(c)(4), enhancing its workforce.

Akebia Therapeutics Awards Stock Options to New Employee Under Nasdaq Rule #United_States #Cambridge #Akebia_Therapeutics #kidney_disease #Nasdaq_AKBA

Fresenius Medical Care Rejoins the DAX 40 Index: A Testament to Their Dedication and Growth Fresenius Medical Care is set to return to Germany's DAX 40 Index on December 27, 2024, marking a significant achievement and recognition of their dedication in serving patients with kidney disease.

Fresenius Medical Care Rejoins the DAX 40 Index: A Testament to Their Dedication and Growth #Germany #kidney_disease #Fresenius_Medical_Care #DAX_40 #Bad_Homburg

Kidney Patients Eager for Xenotransplantation Trials to Address Critical Organ Shortages As organ shortages become critical, kidney patients express urgency for xenotransplantation trials. The National Kidney Foundation emphasizes swift action to advance this promising solution.

Kidney Patients Eager for Xenotransplantation Trials to Address Critical Organ Shortages #United_States #New_York #kidney_disease #National_Kidney_Foundation #Xenotransplantation

Akebia Therapeutics' New Employee Stock Option Grant: A Boost for Talent Acquisition Akebia Therapeutics has granted stock options to new employees as part of its talent acquisition strategy under Nasdaq rules. Learn more!

Akebia Therapeutics' New Employee Stock Option Grant: A Boost for Talent Acquisition #United_States #NASDAQ #Cambridge #Akebia_Therapeutics #kidney_disease